Article

Ethicolegal Aspects of Cancer Genetics

Clinical Genetics Service, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.
Cancer treatment and research 01/2010; 155:1-14. DOI: 10.1007/978-1-4419-6033-7_1
Source: PubMed

ABSTRACT

In the wake of efficacious preventive interventions based on hereditary cancer risk assessment, a number of ethical and legal challenges have emerged. These include issues such as appropriate testing of children and embryos, the "duty to warn" relatives about familial risk, reproductive genetic testing, the risk of genetic discrimination, and equitable access to testing. These and other issues will be discussed within the framework of a bioethical model, with reference to recent case law.

Full-text preview

Available from: medlib.am
  • [Show abstract] [Hide abstract]
    ABSTRACT: Oncologists are asked with increasing frequency to counsel their patients with respect to the medical, psychological and social repercussions of genetic testing for cancer susceptibility that may have been prescribed by physicians or carried out through direct-to-consumer tests. This article critically reviews the main ethical and social implications of BRCA testing, focusing on genetic responsibility and genetic discrimination. Genetic responsibility toward oneself and others is a highly debated implication of genetic testing for cancer predisposition that requires broad considerations of the boundaries between individual and community rights and a reappraisal of the notion of autonomy as relational. Physicians' duty to warn 'at risk' relatives can be an ethical quandary, yet confidentiality is key to the patient-doctor relationship. Mutation carriers may be subject to different forms and degrees of genetic discrimination and many individuals at risk have forgone BRCA testing to avoid potential discrimination. The scientific and medical community, together with patients and the public, has actively engaged against genetic discrimination. The legislation in many countries now protects against genetic discrimination by insurance companies and employers. Legal and regulatory issues are not the final answer to discrimination and profound cultural changes are required to create understanding and acceptance of all differences.
    No preview · Article · Feb 2011 · Annals of Oncology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Genetic counselors and surgeons both have important roles in the care of patients with hereditary cancer predisposition syndromes. Surgeons have the initial responsibility to identify and refer high-risk patients. Genetic counselors' specialized skill sets are then used in the risk assessment and genetic evaluation of such patients and their at-risk family members, and this may be performed in multiple settings. As discussed in this article, these roles and the processes of genetic counseling and genetic testing may be enhanced through multiple surgeon and genetic counselor collaborations. Continued medical management of patients and families with hereditary cancer predisposition syndromes becomes the responsibility of patients and their multiple health care providers. Box 7 provides a list of resources to assist in finding a local genetic counselor. Because there are various opportunities for surgeons and genetic counselors to collaborate, the authors urge surgeons to recognize the importance of, identify, and work in partnership with a local genetic counselor because that relationship sets the stage for optimal care of the cancer patient.
    No preview · Article · Sep 2012 · Advances in Surgery
  • [Show abstract] [Hide abstract]
    ABSTRACT: The discovery of the genes and cellular pathways that play fundamental roles in several diseases, and the understanding of many diseases at a molecular level due to the advances in the field of genomics, have revolutionized the diagnosis, therapy and prevention of human diseases. Application of genetic testing in numerous medical fields, including pharmacogenomics and oncogenomics, raised numerous ethical questions and introduced legal instruments that are aimed at ensuring the appropriate protection of human research participants. For the effective development of human genomics and translation of novel, validated biomarkers into potentially useful clinical applications in personalized medicine, there is a need for clear ethical standards and principles in all phases of clinical research.
    No preview · Article · Jun 2012 · Journal of B.U.ON.: official journal of the Balkan Union of Oncology
Show more